Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

650 results about "Aziridine" patented technology

Aziridines are organic compounds containing the aziridine functional group, a three-membered heterocycle with one amine group (-NH-) and two methylene bridges (-CH₂-). The parent compound is aziridine (or ethylene imine), with molecular formula C₂H₅N.

Fluoropolymer coated films useful for photovoltaic modules

A fluoropolymer coated film comprising polymeric substrate film and fluoropolymer coating on the polymeric substrate film. The fluoropolymer coating comprises fluoropolymer selected from homopolymers and copolymers of vinyl fluoride and homopolymers and copolymers of vinylidene fluoride polymer blended with compatible adhesive polymer comprising functional groups selected from carboxylic acid, sulfonic acid, aziridine, anhydride, amine, isocyanate, melamine, epoxy, hydroxy, anhydride and mixtures thereof. The polymeric substrate film comprises functional groups on its surface that interact with the compatible adhesive polymer to promote bonding of the fluoropolymer coating to the substrate film.
Owner:DUPONT ELECTRONICS INC

Compounds for enzyme inhibition

ActiveUS20050245435A1Inhibiting and reducing HIV infectionAffecting levelBiocideNervous disorderEnzyme inhibitionAziridine
Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsin-like activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.
Owner:ONYX THERAPEUTICS

Compounds for enzyme inhibition

InactiveUS20070105786A1Inhibiting and reducing HIV infectionAffecting levelBiocideNervous disorderEnzyme inhibitionAziridine
Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases associated with the proteasome. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation. Oral administration of these peptide-based proteasome inhibitors is possible due to their bioavailability profiles
Owner:ONYX THERAPEUTICS

Dental impression composition on functionalized polyethers

A dental impression composition comprises a polyether derivative functionalized via the hydroxyl groups of a polyether polyol with groups such as aziridine, epoxide and unsaturated substituents including (meth)acrylic, allyl, vinyl, vinyl ether or maleate groups, wherein the level of cyclic oligomeric polyethers is less than 5.0 weight percent.
Owner:3M DEUTLAND

Ink-jet recording medium with an opaque or semi-opaque layer coated thereon, method for recording an image, and a recorded medium with at least one layer rendered clear or semi-opaque

InactiveUS20040109958A1Extended drying timeAvoid excessive adhesionLayered productsCoatingsAziridineCross linker
The present invention features a multi-layer ink-jet recording medium, suitable for recording images with dye and pigmented inks and thereby providing light-emitting, reflective, glossy, metallic-looking or holographic images, comprising a substrate coated with at least two layers comprising: (a) a first transparent ink-receptive layer comprising a polymeric binder and a cross-linker and optionally having a plasticizer and pigment particles such as alumina and silica coated over the substrate, wherein the cross-linker comprises and azetidinium polymer or a salt thereof, and / or a polyfunctinal aziridine or a salt thereof or a polyfunctional oxazoline or a salt thereof; and (b) a second ink-receptive layer comprising an opaque or semi-opaque coating composition, wherein the opaque or semi-opaque coating composition is capable of accepting a printed image and thereby becoming semi transparent or clearly transparent from application of ink-jet printing ink or similar inks, while presenting a light-emitting, reflective, glossy, metallic-looking or holographic image of high clarity and quality, wherein said first layer is located between said second layer and the substrate in said recording medium and the first and second layers are chemically coupled.
Owner:PIXTERRA

Fluoropolymer coated films useful for photovoltaic modules

A fluoropolymer coated film comprising polymeric substrate film and fluoropolymer coating on the polymeric substrate film. The fluoropolymer coating comprises fluoropolymer selected from homopolymers and copolymers of vinyl fluoride and homopolymers and copolymers of vinylidene fluoride polymer blended with compatible adhesive polymer comprising functional groups selected from carboxylic acid, sulfonic acid, aziridine, anhydride, amine, isocyanate, melamine, epoxy, hydroxy, anhydride and mixtures thereof. The polymeric substrate film comprises functional groups on its surface that interact with the compatible adhesive polymer to promote bonding of the fluoropolymer coating to the substrate film.
Owner:DUPONT ELECTRONICS INC

Compounds For Enzyme Inhibition

InactiveUS20080090785A1Inhibiting and reducing HIV infectionAffecting levelAntibacterial agentsOrganic active ingredientsEnzyme inhibitionAziridine
Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsinlike activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.
Owner:ONYX THERAPEUTICS

Compounds for enzyme inhibition

Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsin-like and PGPH activities of the 20S proteasome can be selectively inhibited with the inventive compounds. The peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus, such as a detectable label. Along with therapeutic utilities, these peptide based compounds can be used in assays useful for screening, monitoring, diagnostic and / or dosing purposes.
Owner:PROTEOLIX INC

Compounds for enzyme inhibition

ActiveUS20060030533A1Inhibiting and reducing HIV infectionAffecting levelOrganic active ingredientsBiocideEnzyme inhibitionAziridine
Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsin-like activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.
Owner:ONYX THERAPEUTICS INC

Compounds for enzyme inhibition

InactiveUS8088741B2Inhibiting and reducing HIV infectionAffecting levelAntibacterial agentsOrganic active ingredientsEnzyme inhibitionAziridine
Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsinlike activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.
Owner:ONYX THERAPEUTICS INC

Fast-acting formulation components, compositions and laundry methods employing same

The present invention relates to formulation components, such as organic catalyst compounds designed with time-controlled bleaching to increase color safety, compositions and laundry methods employing such organic catalyst compounds. More particularly, this invention relates to organic catalysts compounds such as quaternary imine bleach boosting compounds, quaternary oxaziridinium bleaching species, modified amines and amine oxides, imines, and / or oxaziridines, compositions and laundry methods employing such organic catalyst compounds.
Owner:THE PROCTER & GAMBLE COMPANY

Reduction of monomer content and stabilization of polyaziridines

InactiveUS6974874B2Reducing monomeric aziridinesOrganic chemistryPolymer scienceScavenger
The invention relates to a process for reducing the monomeric aziridine content in a polyaziridine forming reaction mixture by adding to the polyaziridine forming reaction mixture an excess of a carbodiimide scavenger wherein the excess is based on the equivalent ratio of scavenger to monomeric aziridine, and to a product obtained by this process and to a coating composition containing the product obtained by the process.
Owner:RGT UNIV OF MICHIGAN +1

Compounds for Enzyme Inhibition

InactiveUS20090203698A1Inhibiting and reducing HIV infectionAffecting levelBiocideNervous disorderEnzyme inhibitionAziridine
Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases associated with the proteasome. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation. Oral administration of these peptide-based proteasome inhibitors is possible due to their bioavailability profiles.
Owner:ONYX THERAPEUTICS INC

Compounds for enzyme inhibition

Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsin-like and PGPH activities of the 20S proteasome can be selectively inhibited with the inventive compounds. The peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus, such as a detectable label. Along with therapeutic utilities, these peptide based compounds can be used in assays useful for screening, monitoring, diagnostic and / or dosing purposes.
Owner:ONYX THERAPEUTICS INC

Fluoropolymer coating compositions containing adhesive polymers and substrate coating process

A liquid fluoropolymer coating composition and a process for using the composition to make fluoropolymer coated polymeric substrates. The liquid fluoropolymer composition comprises fluoropolymer selected from homopolymers and copolymers of vinyl fluoride and homopolymers and copolymers of vinylidene fluoride polymer, solvent, and compatible adhesive polymer comprising functional groups selected from carboxylic acid, sulfonic acid, aziridine, amine, isocyanate, melamine, epoxy, hydroxy, anhydride and mixtures thereof. In the process, the composition is applied to a polymeric substrate comprising functional groups on its surface that interact with said compatible adhesive polymer to promote bonding of said fluoropolymer coating to said substrate. The solvent is removed from the coating composition applied to the substrate to form a fluoropolymer coating on the substrate.
Owner:DUPONT ELECTRONICS INC

Preparation method and application of nano-modified PTFE and polyester-based composite film for preventing fan blades from icing

ActiveCN106313811ASolving non-adhesive technical problemsConvenient engineering constructionSynthetic resin layered productsLaminationPolyesterComposite film
The invention provides a preparation method and application of a nano-modified PTFE and polyester-based composite film for preventing fan blades from icing. The method includes the steps of PTFE film modification, lamination complexing and photo-crosslinked adhesive application. A modifier is prepared from antimony-doped tin oxide nano-crystals, nano-titanium dioxide, nano-silicon carbide, an organic fluorine waterproofing agent and pentaerythritol tri-(3-aziridinyl)-propionate; in lamination complexing, a bonding complexing agent is prepared from 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, vinyl acetate, ethyl carbamate, alpha-linolenic acid, (2)ethoxylated bisphenol A dimethacrylate, trimethylolpropane triacrylate and benzoyl peroxide; a photo-crosslinked adhesive is prepared from a poly[butyl acrylate-glycidyl methacrylate-n-butoxy methacrylamide]copolymer, vinyl acetate, butyl acrylate, an acrylate derivative, a photoinitiator and dimethylformamide. The method and the composite film solve the non-adhesion problem that a PTFE film can not be pasted on the surfaces of fan blades with an adhesive directly.
Owner:NANJING HAOHUI HI TECH CO LTD

Premixed liquid monopropellant solutions and mixtures

InactiveUS6984273B1Requirement is not sufficientLow toxicityExplosivesHydroxylamineDetonation
Nondetonable, or low detonation sensitivity, substantially nontoxic liquid monopropellants are provided. The liquid propellants are formed from aqueous solutions of solid oxidizers in liquid oxidizers and water soluble liquid fuels and formulated to have a freezing point less than −10° C. Liquid oxidizers may be inorganic or organic aqueous solutions, with hydrogen peroxide being preferred. Preferred solid oxidizers are water soluble nitrates including ammonium dinitramide, aminoguanidine dinitrate, ammonium nitrate, hydroxylamine nitrate, hydrazine nitrate, guanidine nitrate and aminoguanidine nitrate. Preferred liquid fuels are water soluble alcohols, amines and amine nitrates, hydroxyethyl hydrazine, hydroxyethylhydrazine nitrate, cyanoguanidine, guanidines, aminoguanidines, triaminoguanidines, and their nitrate salts, ethanolamine dinitrate, ethylenediamine dinitrate, polyvinyl nitrate, and aziridine.
Owner:AEROJET GENERAL CORP

Aziridine bisphenol ethers and related compounds and methods for their use

Compounds having a structure of Formula I:or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R, R1, R2, R3, R4, M1, M2, X, L1, L2, J1, J2, a1, a2, b1 and b2 are as defined herein, and wherein at least one of M2 or L2 is a moiety comprising an aziridine, acrylamide or sulfonate functional group, are provided. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided.
Owner:THE UNIV OF BRITISH COLUMBIA +1

Aziridine crosslinking agents for acrylic adhesives

A crosslinkable, pre-adhesive composition is described comprising an acid-functional (meth)acrylate copolymer and an aziridine crosslinking agent, which when crosslinked provides a pressure-sensitive adhesive and pressure-sensitive adhesive articles.
Owner:3M INNOVATIVE PROPERTIES CO

Polymer electrolyte and a lithium secondary battery having the same

A polymer electrolyte includes a gel-forming polymer electrolyte including a gel-forming compound connected at metal cations, and an organic electrolyte of a lithium salt and an aprotic solvent. The polymer electrolyte includes a gel-forming polymer electrolyte that includes at least one aziridine ring-containing compound, and an organic electrolyte of lithium salt and aprotic solvent.
Owner:SAMSUNG SDI CO LTD

Application of amine-tethered solid sorbents to CO2 fixation from air

A method for capturing CO2 from the ambient air by the use of solid tethered amine adsorbents, where the amine adsorbents are tethered to a substrate selected from the group of silica, metal oxides and polymer resins. The tethered amines are joined to the substrate by covalent bonding, achieved either by the ring-opening polymerization of aziridine on porous and non-porous supports, or by the reaction of mono-, di-, or tri-aminosilanes, with silica or a metal oxide having hydroxyl surface groups. The method includes the adsorption of CO2 from ambient air, the regeneration of the adsorbent at elevated temperatures not above 120° C. and the separation of purified CO2, followed by recycling of the regenerated tethered adsorbent for further adsorption of CO2 from the ambient atmosphere.
Owner:GLOBAL THERMOSTAT OPERATIONS LLC

Acrylic pressure-sensitive adhesives with aziridine crosslinking agents

A pre-adhesive composition is described comprising an acid-functional (meth)acrylate copolymer and an aziridine crosslinking agent, which when crosslinked provides a pressure-sensitive adhesive and pressure-sensitive adhesive articles.
Owner:3M INNOVATIVE PROPERTIES CO

Ambient temperature rapid self-polymerization compositions of high cross-linked or linear type beta-amino-ester alternative co-polymers and their applications

InactiveUS20070299211A1Self-polymerization can be very rapidSelf-polymerization rate can be controlledCross-linkAmino esters
Self-polymerization of mono-aziridine (or azetidine) and multi-aziridine (or azetidine) containing compounds with vinyl group containing organic acid, such as acrylic acid (AA), 2-methylenesuccinic acid, 2,3-dimethylenesuccinic acid and etc, at ambient temperature results in the new type of cross-linked and linear type copolymers, respectively.The polymerization of multi-functional aziridine (or azetidine) containing compounds with vinyl group containing organic acid results in the formation of high cross-linked polymers. The self-polymerization takes place at ambient temperature and the resultants, cross-linked polymeric networked materials, are solvent insoluble and potential for adhesive, composite matrix and other applications. These insoluble materials are hydrolyzed in an acidic or basic condition to form the water soluble β-amino acids.A linear poly(β-aminoester) is obtained from the self-polymerization of vinyl group containing organic acid with mono-aziridine (or azetidine) containing compound at ambient temperature. poly(β-aminoester) is applicable for gene transfer, controlled drug release and other applications. This self-polymerization process offers a convenient route for preparing poly(β-aminoesters).
Owner:TAMKANG UNIVERSITY

Compounds for proteasome enzyme inhibition

ActiveUS8198270B2Inhibiting and reducing HIV infectionAffecting levelBiocideNervous disorderEnzyme inhibitionAziridine
Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsin-like activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.
Owner:ONYX THERAPEUTICS INC

Polyacrylate grafted modified polyester water-based coating and preparation method thereof

The invention discloses a preparation method of a polyacrylate grafted modified polyester water-based coating. The preparation method is as follows: first, selecting a dihydric alcohol and a dibasic acid for a copolycondensation reaction at 240 DEG C for synthesis of a polyester with grafting activity, then adding the dibasic acid or a polybasic acid for polyester depolymerization and end capping for synthesis of water-dispersible polyester resin, then dissolving the water-dispersible polyester resin with a water soluble cosolvent, at 105 DEG C dropping a mixed liquid of a functional monomer, an acrylate monomer, a styrene monomer and an organic peroxide initiator for a free radical grafting copolymerization reaction for synthesis of a solution of water-dispersible-type polyacrylate grafted modified polyester resin with a water-dispersible main chain and a water-soluble graft chain, adding an amine neutralizer for neutralizing the solution of the water-dispersible-type polyacrylate grafted modified polyester resin, mixing the neutralized solution of the polyacrylate grafted modified polyester resin with an amino resin curing agent or an aziridine curing agent, a coating additive and deionized water for preparation of the polyacrylate grafted modified polyester water-based coating. The polyacrylate grafted modified polyester water-based coating has the advantages of a polyester coating and a polyacrylate coating, and is high in cured paint film glossiness and strong in water resistance.
Owner:GUANGDONG YATU CHEM

Compounds for proteasome enzyme inhibition

InactiveUS20120329705A1Inhibiting and reducing HIV infectionAffecting levelBiocideOrganic active ingredientsEnzyme inhibitionAziridine
Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsin-like activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.
Owner:ONYX THERAPEUTICS INC

Acrylic pressure-sensitive adhesives with aziridine crosslinking agents

A pre-adhesive composition is described comprising an acid-functional (meth)acrylate copolymer and an aziridine crosslinking agent, which when crosslinked provides a pressure-sensitive adhesive and pressure-sensitive adhesive articles.
Owner:3M INNOVATIVE PROPERTIES CO

Water-soluble fullerene and preparation and application methods thereof

The invention relates to water-soluble fullerene and preparing method thereof, can effectively solve the problems of poor solubility, low photosensitive activity and poor biocompatibility of the conventional fullerene, and adopts the technical scheme that water-soluble polymer polyethylene imine is connected to a fullerene molecule through chemical bonds to obtain water-soluble fullerene; and theweight ratio of polyethylene imine to fullerene is 0.08 to 0.12 : 1. The method comprises the following steps: the fullerene is reacted with an ammoniation reagent to obtain amino fullerene; amino fullerene is reacted with aziridine in such a manner that under the existence of protonated hydrogen ions, aziridine is grafted on amino groups continuously; and finally, the polymer of fullerene and polyethylene imine (namely water-soluble fullerene) is obtained. The water-soluble fullerene prepared according to the invention has the advantages that the characteristics of fullerene are not damaged;the water dispersibility is high; the toxicity is low; the stability is favorable; the preparation method is simple; the cost is low; and the water-soluble fullerene serves as a photosensitizer or a medicine carrier during the preparation of medicines curing cancers.
Owner:ZHENGZHOU UNIV

Water-based matt handfeel oil and preparation method thereof

The invention relates to the technical field of preparation of handfeel oil, in particular to water-based matte handfeel oil and a preparation method thereof. The water-based matt handfeel oil consists of the following raw materials in part by weight: 72 to 87 parts of matt resin, 7 to 14 parts of bright resin, 2 to 5 parts of alcohol, 1 to 4 parts of water, 1 to 4 parts of handfeel agent, 0.5 to 1.5 parts of anti-sticking agent, 2 to 4 parts of flatting agent, 2 to 8 parts of wear-resistant agent, 0.1 to 1.5 parts of mildew preventive, 0.2 to 0.6 part of defoaming agent, 0.2 to 0.8 part of thickening agent and 0.5 to 1.4 parts of handfeel crosslinking agent. By adoption of polyester polyol and aziridine crosslinking agent, the wear resistance, the attachment fastness and the chemical resistance of the handfeel oil are greatly improved and high practicability is achieved. The preparation method is simple in process, low in production cost and favorable for popularization and application.
Owner:广东佳景科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products